{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:22:45Z","timestamp":1792783365195,"version":"4.5.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"DEAL","id":[{"id":"https:\/\/ror.org\/04qk3kg25","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Cardiac implantable electronic device (CIED) infection remains one of the most serious complications of device therapy, causing significant morbidity, mortality, healthcare utilization, and costs. Despite advances in device technology and preventive strategies, infection rates have not declined and may be increasing. This review summarizes current evidence on CIED infection prevention and device pocket management, with a focus on risk-based prevention, procedural strategies, and emerging technologies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Increasing evidence supports individualized infection-prevention strategies based on patient-, procedure-, and device-related risk factors. Contemporary approaches extend beyond peri-procedural antibiotic prophylaxis and include structured risk stratification, optimization of modifiable risk factors, meticulous pocket management, prevention of pocket hematoma formation, taurolidine containing adjuncts and selective use of antibacterial technologies such as absorbable antibiotic envelopes. Novel device platforms including leadless pacemakers, subcutaneous and extravascular implantable cardioverter-defibrillators, and conduction system pacing may further reduce infectious burden in selected patients. Emerging technologies including antimicrobial biomaterials, artificial intelligence-assisted risk prediction, and digital wound surveillance may facilitate precision-based infection prevention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>CIED infection prevention increasingly requires a comprehensive and individualized approach that addresses the entire contamination - biofilm - infection pathway. Contemporary prevention strategies integrate patient optimization, procedural excellence, pocket management, and selective use of adjunctive technologies. Future advances are likely to shift infection prevention toward precision-based interventions tailored to individual patient risk profiles and device requirements.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11886-026-02436-7","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:24:21Z","timestamp":1792056261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Infection Prevention and Device Pocket Management in Cardiac Implantable Electronic Devices: Emerging Strategies"],"prefix":"10.1007","volume":"28","author":[{"given":"Benito Jonas","family":"Baldauf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ojan","family":"Assadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Giaccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Notarstefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Adiyaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hemels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest W.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Bonnemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"issue":"1","key":"2436_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s12872-026-06124-w","volume":"26","author":"B Baldauf","year":"2026","unstructured":"Baldauf B, et al. Trends in cardiac implantable electronic device infections: 2015 to 2019. BMC Cardiovasc Disord. 2026;26(1):503.","journal-title":"BMC Cardiovasc Disord"},{"issue":"10","key":"2436_CR2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jacc.2011.04.033","volume":"58","author":"AJ Greenspon","year":"2011","unstructured":"Greenspon AJ, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011;58(10):1001\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2436_CR3","first-page":"1071","volume":"5","author":"M Dai","year":"2019","unstructured":"Dai M, et al. Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A Population-Based Study. JACC: Clin Electrophysiol. 2019;5(9):1071\u201380.","journal-title":"JACC: Clin Electrophysiol"},{"key":"2436_CR4","doi-asserted-by":"crossref","unstructured":"Cha Y-M et al. 2026 HRS\/AHA\/APHRS\/EHRA\/IDSA\/LAHRS\/PACES\/STS expert consensus statement update on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm, 2026.","DOI":"10.1016\/j.hrthm.2026.04.015"},{"issue":"1","key":"2436_CR5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/europace\/euab232","volume":"24","author":"M Glikson","year":"2022","unstructured":"Glikson M, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Europace. 2022;24(1):71\u2013164.","journal-title":"Europace"},{"issue":"21","key":"2436_CR6","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1093\/eurheartj\/ehaa010","volume":"41","author":"C Blomstrom-Lundqvist","year":"2020","unstructured":"Blomstrom-Lundqvist C, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020;41(21):2012\u201332. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa010","journal-title":"Eur Heart J"},{"issue":"1","key":"2436_CR7","doi-asserted-by":"publisher","first-page":"30513","DOI":"10.1038\/s41598-024-82622-1","volume":"14","author":"B Baldauf","year":"2024","unstructured":"Baldauf B, et al. Prevalence of cardiac implantable electronic device infections in Germany in 2015. Sci Rep. 2024;14(1):30513.","journal-title":"Sci Rep"},{"issue":"3","key":"2436_CR8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/microorganisms12030537","volume":"12","author":"E Guti\u00e9rrez-Carretero","year":"2024","unstructured":"Guti\u00e9rrez-Carretero E, et al. Mortality and Costs of Cardiac Implantable Electronic Device (CIED) Infections According to the Therapeutic Approach: A Single-Center Cohort Study. Microorganisms. 2024;12(3):537. https:\/\/doi.org\/10.3390\/microorganisms12030537","journal-title":"Microorganisms"},{"issue":"2","key":"2436_CR9","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1161\/CIR.0000000000001187","volume":"149","author":"LM Baddour","year":"2024","unstructured":"Baddour LM, et al. Update on Cardiovascular Implantable Electronic Device Infections and Their Prevention, Diagnosis, and Management: A Scientific Statement From the American Heart Association: Endorsed by the International Society for Cardiovascular Infectious Diseases. Circulation. 2024;149(2):e201\u201316.","journal-title":"Circulation"},{"issue":"1","key":"2436_CR10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s44259-024-00046-3","volume":"2","author":"HY Liu","year":"2024","unstructured":"Liu HY, Prentice EL, Webber MA. Mechanisms of antimicrobial resistance in biofilms. npj Antimicrobials Resist. 2024;2(1):27.","journal-title":"npj Antimicrobials Resist"},{"issue":"6","key":"2436_CR11","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3390\/microorganisms11061614","volume":"11","author":"S Sharma","year":"2023","unstructured":"Sharma S, et al. Microbial Biofilm: A Review on Formation, Infection, Antibiotic Resistance, Control Measures, and Innovative Treatment. Microorganisms. 2023;11(6):1614.","journal-title":"Microorganisms"},{"key":"2436_CR12","doi-asserted-by":"publisher","unstructured":"Salucci A et al. Impact of taurolidine use during cardiac electronic implantable device implantation in heart failure patients. EP Europace. 2024;26(Supplement_1):euae102\u2013524. https:\/\/doi.org\/10.1093\/europace\/euae102.524","DOI":"10.1093\/europace\/euae102.524"},{"issue":"5","key":"2436_CR13","doi-asserted-by":"crossref","first-page":"e011740","DOI":"10.1161\/CIRCEP.122.011740","volume":"16","author":"CR Ellis","year":"2023","unstructured":"Ellis CR, et al. Randomized Trial of Stand-Alone Use of the Antimicrobial Envelope in High-Risk Cardiac Device Patients. Circ Arrhythm Electrophysiol. 2023;16(5):e011740.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"4","key":"2436_CR14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5603\/CJ.a2018.0024","volume":"26","author":"M Grabowski","year":"2019","unstructured":"Grabowski M, et al. Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center. Cardiol J. 2019;26(4):360\u20137.","journal-title":"Cardiol J"},{"issue":"3","key":"2436_CR15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s40883-019-00116-3","volume":"6","author":"SVVSN P","year":"2020","unstructured":"P SVVSN, P SVVS. A Review on Surface Modifications and Coatings on Implants to Prevent Biofilm. Regenerative Eng Translational Med. 2020;6(3):330\u201346.","journal-title":"Regenerative Eng Translational Med"},{"issue":"2","key":"2436_CR16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.smim.2007.11.004","volume":"20","author":"JM Anderson","year":"2008","unstructured":"Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20(2):86\u2013100.","journal-title":"Semin Immunol"},{"issue":"7","key":"2436_CR17","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3390\/microorganisms10071259","volume":"10","author":"EG Di Domenico","year":"2022","unstructured":"DiDomenico EG, Oliva A, Guembe M. The Current Knowledge on the Pathogenesis of Tissue and Medical Device-Related Biofilm Infections. Microorganisms. 2022;10(7):1259. https:\/\/doi.org\/10.3390\/microorganisms10071259","journal-title":"Microorganisms"},{"issue":"5","key":"2436_CR18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.tcm.2025.02.001","volume":"35","author":"S Christie","year":"2025","unstructured":"Christie S, McGregor M, Krahn AD. Cardiac implantable electronic device infection. Trends Cardiovasc Med. 2025;35(5):310\u20136.","journal-title":"Trends Cardiovasc Med"},{"issue":"Suppl 4","key":"2436_CR19","doi-asserted-by":"crossref","first-page":"iv11","DOI":"10.1093\/europace\/euab071","volume":"23","author":"C Blomstrom-Lundqvist","year":"2021","unstructured":"Blomstrom-Lundqvist C, Ostrowska B. Prevention of cardiac implantable electronic device infections: guidelines and conventional prophylaxis. Europace. 2021;23(Suppl 4):iv11\u20139.","journal-title":"Europace"},{"key":"2436_CR20","doi-asserted-by":"crossref","unstructured":"Mohapatra S. Sterilization and disinfection. In: Prabhakar H, editor. Essentials of Neuroanesthesia. London: Academic Press; 2017. p. 929\u2013994.","DOI":"10.1016\/B978-0-12-805299-0.00059-2"},{"issue":"14","key":"2436_CR21","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.3390\/jcm11143929","volume":"11","author":"A Polewczyk","year":"2022","unstructured":"Polewczyk A, et al. Early, Delayed and Late Cardiac Implantable Electronic Device Infections: Do the Timing of Onset and Pathogens Matter? J Clin Med. 2022;11(14):3929. https:\/\/doi.org\/10.3390\/jcm11143929","journal-title":"J Clin Med"},{"issue":"1","key":"2436_CR22","first-page":"50","volume":"7","author":"MR Sohail","year":"2021","unstructured":"Sohail MR, et al. Clinical Presentation, Timing, and Microbiology of CIED Infections: An Analysis of the WRAP-IT Trial. JACC: Clin Electrophysiol. 2021;7(1):50\u201361.","journal-title":"JACC: Clin Electrophysiol"},{"issue":"1","key":"2436_CR23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.31083\/j.rcm2501019","volume":"25","author":"C Hoyos","year":"2024","unstructured":"Hoyos C, et al. Measures to Prevent Infection in Cardiac Implantable Electronic Device Replacements or Upgrades. Rev Cardiovasc Med. 2024;25(1):19.","journal-title":"Rev Cardiovasc Med"},{"key":"2436_CR24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jdsr.2021.05.003","volume":"57","author":"S Kreve","year":"2021","unstructured":"Kreve S, Reis ACD. Bacterial adhesion to biomaterials: What regulates this attachment? A review. Japanese Dent Sci Rev. 2021;57:85\u201396.","journal-title":"Japanese Dent Sci Rev"},{"issue":"7","key":"2436_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41579-018-0019-y","volume":"16","author":"CR Arciola","year":"2018","unstructured":"Arciola CR, Campoccia D, Montanaro L. Implant infections: adhesion, biofilm formation and immune evasion. Nat Rev Microbiol. 2018;16(7):397\u2013409.","journal-title":"Nat Rev Microbiol"},{"key":"2436_CR26","doi-asserted-by":"crossref","first-page":"128597","DOI":"10.1016\/j.micres.2026.128597","volume":"311","author":"W Ma","year":"2026","unstructured":"Ma W, et al. Biofilm formation: Regulatory mechanisms and therapeutic strategies. Microbiol Res. 2026;311:128597.","journal-title":"Microbiol Res"},{"issue":"2","key":"2436_CR27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2025.10.042","volume":"87","author":"A Da Costa","year":"2026","unstructured":"Da Costa A, et al. Chlorhexidine vs Povidone-Iodine Alcohol Solutions for Cardiac Implantable Electronic Devices. JACC. 2026;87(2):200\u201311.","journal-title":"JACC"},{"issue":"18","key":"2436_CR28","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/01.CIR.97.18.1796","volume":"97","author":"A Da Costa","year":"1998","unstructured":"Da Costa A, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation. 1998;97(18):1796\u2013801.","journal-title":"Circulation"},{"key":"2436_CR29","doi-asserted-by":"crossref","unstructured":"Aydin A, et al. Iodinated Adhesive Drapes for Repeat Cardiac Implantable Device Implantation: A Randomized Clinical Trial. JAMA Cardiology; 2025.","DOI":"10.1001\/jamacardio.2025.2835"},{"issue":"2","key":"2436_CR30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.hroo.2023.12.002","volume":"O2","author":"M Golian","year":"2024","unstructured":"Golian M, et al. Adherent skin barrier drape use is associated with a reduced risk of cardiac implantable device infection: Results from a prospective study of 14,225 procedures. Heart Rhythm. 2024;O2(2):103\u201312.","journal-title":"Heart Rhythm"},{"issue":"12","key":"2436_CR31","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.hrthm.2021.07.011","volume":"18","author":"KG Tarakji","year":"2021","unstructured":"Tarakji KG, et al. Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysis. Heart Rhythm. 2021;18(12):2080\u20136.","journal-title":"Heart Rhythm"},{"key":"2436_CR32","doi-asserted-by":"crossref","unstructured":"Mittal S et al. The World-Wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) Trial: Long-Term Follow-Up. Heart Rhythm, 2020.","DOI":"10.1016\/j.hrthm.2020.02.011"},{"issue":"5","key":"2436_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/mps6050086","volume":"6","author":"R Vonthein","year":"2023","unstructured":"Vonthein R, et al. The European TauroPace\u2122 Registry. Methods Protoc. 2023;6(5):86. https:\/\/doi.org\/10.3390\/mps6050086","journal-title":"Methods Protoc"},{"issue":"1","key":"2436_CR34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.hrthm.2018.07.006","volume":"16","author":"NEG Beurskens","year":"2019","unstructured":"Beurskens NEG, et al. Leadless pacemaker implantation after explantation of infected conventional pacemaker systems: A viable solution? Heart Rhythm. 2019;16(1):66\u201371.","journal-title":"Heart Rhythm"},{"issue":"6","key":"2436_CR35","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1053\/j.jvca.2025.01.029","volume":"39","author":"JE Tang","year":"2025","unstructured":"Tang JE, et al. New Horizons in Nontransvenous Arrhythmia Management: Aurora Extravascular ICD. J Cardiothorac Vasc Anesth. 2025;39(6):1564\u201370.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"7","key":"2436_CR36","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.mayocp.2018.11.029","volume":"94","author":"Z Esquer Garrigos","year":"2019","unstructured":"Esquer Garrigos Z, et al. Clinical Presentation, Management, and Outcomes of Cardiovascular Implantable Electronic Device Infections Due to Gram-Negative Versus Gram-Positive Bacteria. Mayo Clin Proc. 2019;94(7):1268\u201377.","journal-title":"Mayo Clin Proc"},{"key":"2436_CR37","unstructured":"Pre-. surgical Nasal Decolonization of Staphylococcus aureus: A Health Technology Assessment. Ont Health Technol Assess Ser. 2022;22(4):1\u2013165."},{"issue":"1","key":"2436_CR38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa0808939","volume":"362","author":"LG Bode","year":"2010","unstructured":"Bode LG, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med. 2010;362(1):9\u201317.","journal-title":"N Engl J Med"},{"issue":"10","key":"2436_CR39","first-page":"636","volume":"26","author":"Y Kakzanov","year":"2024","unstructured":"Kakzanov Y, et al. Decolonization of Staphylococcus aureus Prior to Cardiac Implantable Electronic Device Implantation: Evaluating Preoperative Yield. Isr Med Assoc J. 2024;26(10):636\u201342.","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"2436_CR40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000481545","volume":"31","author":"A Kramer","year":"2017","unstructured":"Kramer A, et al. Consensus on Wound Antisepsis: Update 2018. Skin Pharmacol Physiol. 2017;31(1):28\u201358.","journal-title":"Skin Pharmacol Physiol"},{"issue":"24","key":"2436_CR41","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1207290","volume":"368","author":"SS Huang","year":"2013","unstructured":"Huang SS, et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med. 2013;368(24):2255\u201365.","journal-title":"N Engl J Med"},{"issue":"6","key":"2436_CR42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.31083\/j.rcm2406176","volume":"24","author":"G S\u0142awi\u0144ski","year":"2023","unstructured":"S\u0142awi\u0144ski G, Kempa M, Przybylski A. Prevention of Cardiac Implantable Electronic Device Infections: A Review. Rev Cardiovasc Med. 2023;24(6):176.","journal-title":"Rev Cardiovasc Med"},{"key":"2436_CR43","doi-asserted-by":"publisher","unstructured":"Biniam B et al. Nine-year single-center audit of cardiac implantable electronic device (CIED) procedures and operator-specific outcomes. EP Europace. 2026;28(Supplement_1):euag105\u2013875. https:\/\/doi.org\/10.1093\/europace\/euag105.875","DOI":"10.1093\/europace\/euag105.875"},{"key":"2436_CR44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jhin.2025.02.007","volume":"159","author":"MM Carl\u00e0","year":"2025","unstructured":"Carl\u00e0 MM, et al. Safety outcomes of a mobile laminar airflow device to perform intravitreal injections: a 3-year retrospective study. J Hosp Infect. 2025;159:88\u201391.","journal-title":"J Hosp Infect"},{"issue":"5","key":"2436_CR45","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/europace\/euv003","volume":"17","author":"B Nowak","year":"2015","unstructured":"Nowak B, et al. Association between hospital procedure volume and early complications after pacemaker implantation: results from a large, unselected, contemporary cohort of the German nationwide obligatory external quality assurance programme. Europace. 2015;17(5):787\u201393.","journal-title":"Europace"},{"issue":"8","key":"2436_CR46","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.jacc.2005.04.063","volume":"46","author":"M Al-Khatib Sana","year":"2005","unstructured":"Al-Khatib Sana M, et al. The Relation Between Patients\u2019 Outcomes and the Volume of Cardioverter-Defibrillator Implantation Procedures Performed by Physicians Treating Medicare Beneficiaries. JACC. 2005;46(8):1536\u201340.","journal-title":"JACC"},{"key":"2436_CR47","unstructured":"NHS. Hospital Guide by NHS. 2025."},{"issue":"1","key":"2436_CR48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/CIRCEP.108.795906","volume":"2","author":"JC de Oliveira","year":"2009","unstructured":"de Oliveira JC, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol. 2009;2(1):29\u201334.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2436_CR49","doi-asserted-by":"crossref","unstructured":"Geerlings SE, Hoepelman AIM. Immune dysfunction in patients with diabetes mellitus (DM). Volume 26. FEMS Immunology & Medical Microbiology; 1999. pp. 259\u201365. 3\u20134.","DOI":"10.1111\/j.1574-695X.1999.tb01397.x"},{"issue":"3","key":"2436_CR50","doi-asserted-by":"crossref","first-page":"100127","DOI":"10.1016\/j.imj.2024.100127","volume":"3","author":"CD Iwu","year":"2024","unstructured":"Iwu CD. Global research landscape of health care-associated infections among immunocompromised people before and after the start of the COVID-19 pandemic. Infect Med (Beijing). 2024;3(3):100127.","journal-title":"Infect Med (Beijing)"},{"key":"2436_CR51","doi-asserted-by":"publisher","first-page":"101159404","DOI":"10.3389\/fmolb.2023.1159404","volume":"10","author":"T \u00c7etinarslan","year":"2023","unstructured":"\u00c7etinarslanT, K\u00fcmper L, F\u00f6lster-Holst R. The immunological and structural epidermal barrier dysfunction and skin microbiome in atopic dermatitis-an update. Front Mol Biosci 2023;10:1159404. https:\/\/doi.org\/10.3389\/fmolb.2023.1159404","journal-title":"Front Mol Biosci 2023 Aug"},{"issue":"5","key":"2436_CR52","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.hrthm.2015.01.035","volume":"12","author":"D Lakkireddy","year":"2015","unstructured":"Lakkireddy D, et al. IMpact of pocKet rEvision on the rate of InfecTion and other CompLications in patients rEquiring pocket mAnipulation for generator replacement and\/or lead replacement or revisioN (MAKE IT CLEAN): A prospective randomized study. Heart Rhythm. 2015;12(5):950\u20136.","journal-title":"Heart Rhythm"},{"issue":"suppl_1","key":"2436_CR53","doi-asserted-by":"publisher","first-page":"5580","DOI":"10.1093\/eurheartj\/eht310.P5580","volume":"34","author":"M Okada","year":"2013","unstructured":"Okada M, et al. Bacterial colonization on the cardiovascular implantable electronic devices. Eur Heart J. 2013;34(suppl_1):5580. https:\/\/doi.org\/10.1093\/eurheartj\/eht310.P5580","journal-title":"Eur Heart J"},{"issue":"1","key":"2436_CR54","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/europace\/eup334","volume":"12","author":"T Kleemann","year":"2010","unstructured":"Kleemann T, et al. Prevalence of bacterial colonization of generator pockets in implantable cardioverter defibrillator patients without signs of infection undergoing generator replacement or lead revision. Europace. 2010;12(1):58\u201363.","journal-title":"Europace"},{"issue":"9","key":"2436_CR55","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/europace\/eun191","volume":"10","author":"M Pichlmaier","year":"2008","unstructured":"Pichlmaier M, et al. High prevalence of asymptomatic bacterial colonization of rhythm management devices. Europace. 2008;10(9):1067\u201372.","journal-title":"Europace"},{"issue":"6","key":"2436_CR56","doi-asserted-by":"publisher","first-page":"euad159","DOI":"10.1093\/europace\/euad159","volume":"25","author":"M Frausing","year":"2023","unstructured":"Frausing M, et al. Cost-effectiveness of an antibacterial envelope for infection prevention in patients undergoing cardiac resynchronization therapy reoperations in Denmark. EP Europace. 2023;25(6):euad159. https:\/\/doi.org\/10.1093\/europace\/euad159","journal-title":"EP Europace"},{"issue":"4","key":"2436_CR57","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.chest.2018.11.026","volume":"155","author":"TS Metkus","year":"2019","unstructured":"Metkus TS, et al. Complications and Outcomes of Temporary Transvenous Pacing: An Analysis of >\u2009360,000 Patients From the National Inpatient Sample. Chest. 2019;155(4):749\u201357.","journal-title":"Chest"},{"issue":"1","key":"2436_CR58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/jvd4010003","volume":"4","author":"B Baldauf","year":"2025","unstructured":"Baldauf B, et al. Central Vascular Access Devices: Current Standards and Future Implications. J Vascular Dis. 2025;4(1):3.","journal-title":"J Vascular Dis"},{"issue":"44","key":"2436_CR59","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1093\/eurheartj\/ehy413","volume":"39","author":"DH Birnie","year":"2018","unstructured":"Birnie DH, et al. Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2). Eur Heart J. 2018;39(44):3973\u20139.","journal-title":"Eur Heart J"},{"issue":"22","key":"2436_CR60","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","volume":"368","author":"DH Birnie","year":"2013","unstructured":"Birnie DH, et al. Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med. 2013;368(22):2084\u201393.","journal-title":"N Engl J Med"},{"key":"2436_CR61","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12872-016-0251-1","volume":"16","author":"O Beton","year":"2016","unstructured":"Beton O, et al. Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid? BMC Cardiovasc Disord. 2016;16:73.","journal-title":"BMC Cardiovasc Disord"},{"issue":"Supplement1","key":"2436_CR62","doi-asserted-by":"publisher","first-page":"euag105","DOI":"10.1093\/europace\/euag105.856","volume":"28","author":"R Chantrakul","year":"2026","unstructured":"Chantrakul R, Boonyapisit W. Prevention of bleeding complications with local tranexamic acid use during cardiovascular implantable electronic device implantation. EP Europace. 2026;28(Supplement1):euag105\u2013856. https:\/\/doi.org\/10.1093\/europace\/euag105.856","journal-title":"EP Europace"},{"issue":"24","key":"2436_CR63","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/j.jacc.2018.09.068","volume":"72","author":"AD Krahn","year":"2018","unstructured":"Krahn AD, et al. Prevention of Arrhythmia Device Infection Trial: The PADIT Trial. J Am Coll Cardiol. 2018;72(24):3098\u2013109.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2436_CR64","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/europace\/euv053","volume":"17","author":"KA Polyzos","year":"2015","unstructured":"Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace. 2015;17(5):767\u201377.","journal-title":"Europace"},{"issue":"1","key":"2436_CR65","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/jpm12010091","volume":"12","author":"G Boriani","year":"2022","unstructured":"Boriani G, et al. Incidence and Predictors of Infections and All-Cause Death in Patients with Cardiac Implantable Electronic Devices: The Italian Nationwide RI-AIAC Registry. J Personalized Med. 2022;12(1):91.","journal-title":"J Personalized Med"},{"issue":"7","key":"2436_CR66","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/jce.12684","volume":"26","author":"N Shariff","year":"2015","unstructured":"Shariff N, et al. Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation. J Cardiovasc Electrophysiol. 2015;26(7):783\u20139.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"3","key":"2436_CR67","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/pace.12063","volume":"36","author":"MJ Kolek","year":"2013","unstructured":"Kolek MJ, et al. Use of an Antibacterial Envelope is Associated with Reduced Cardiac Implantable Electronic Device Infections in High-Risk Patients. Pacing Clin Electrophysiol. 2013;36(3):354\u201361.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"3","key":"2436_CR68","doi-asserted-by":"crossref","first-page":"e012446","DOI":"10.1161\/CIRCEP.123.012446","volume":"17","author":"E Maclean","year":"2024","unstructured":"Maclean E, et al. The BLISTER Score: A Novel, Externally Validated Tool for Predicting Cardiac Implantable Electronic Device Infections, and Its Cost-Utility Implications for Antimicrobial Envelope Use. Circ Arrhythm Electrophysiol. 2024;17(3):e012446.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"21","key":"2436_CR69","doi-asserted-by":"publisher","first-page":"6556","DOI":"10.3390\/jcm11216556","volume":"11","author":"M Malag\u00f9","year":"2022","unstructured":"Malag\u00f9 M, et al. Risk scores for cardiac implantable electronic device infection: Which one to believe in? J Clin Med. 2022;11(21):6556. https:\/\/doi.org\/10.3390\/jcm11216556","journal-title":"J Clin Med"},{"key":"2436_CR70","doi-asserted-by":"publisher","unstructured":"Tarakji KG et al. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection. N Engl J Med, 2019. 380:1895-1905 https:\/\/doi.org\/10.1056\/NEJMoa19011","DOI":"10.1056\/NEJMoa19011"},{"issue":"19","key":"2436_CR71","doi-asserted-by":"crossref","first-page":"e15490","DOI":"10.1097\/MD.0000000000015490","volume":"98","author":"CF Chen","year":"2019","unstructured":"Chen CF, et al. Efficacy, safety, and in-hospital outcomes of subcutaneous versus transvenous implantable defibrillator therapy: A meta-analysis and systematic review. Med (Baltim). 2019;98(19):e15490.","journal-title":"Med (Baltim)"},{"issue":"4","key":"2436_CR72","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/jce.14966","volume":"32","author":"T Ananwattanasuk","year":"2021","unstructured":"Ananwattanasuk T, et al. Lead damage after cardiac implantable device replacement procedure: Comparison between electrical plasma tool and electrocautery. J Cardiovasc Electrophysiol. 2021;32(4):1124\u20138.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2436_CR73","doi-asserted-by":"crossref","unstructured":"Atti V, et al. Subclavian and Axillary Vein Access Versus Cephalic Vein Cutdown for Cardiac Implantable Electronic Device Implantation: A Meta-Analysis. Volume 6. JACC: Clinical Electrophysiology; 2020. pp. 661\u201371. 6.","DOI":"10.1016\/j.jacep.2020.01.006"},{"issue":"4","key":"2436_CR74","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/jce.14939","volume":"32","author":"Z Akhtar","year":"2021","unstructured":"Akhtar Z, et al. Multi-lead cephalic venous access and long-term performance of high-voltage leads. J Cardiovasc Electrophys. 2021;32(4):1131\u20139.","journal-title":"J Cardiovasc Electrophys"},{"key":"2436_CR75","doi-asserted-by":"crossref","unstructured":"Rowntree C, Chew KY. Technical Considerations for Wound Closure: A Plastic Surgery Perspective Part I. Techniques in Vascular and Interventional Radiology, 2026: p. 101130.","DOI":"10.1016\/j.tvir.2026.101130"},{"issue":"7","key":"2436_CR76","doi-asserted-by":"crossref","first-page":"e03479","DOI":"10.1002\/adhm.202503479","volume":"15","author":"B Baldauf","year":"2026","unstructured":"Baldauf B, et al. Antimicrobial Efficacy of a Taurolidine-Based Antimicrobial Compound on Contaminated Surfaces Simulated in a Standardized 4-Field Test. Adv Healthc Mater. 2026;15(7):e03479.","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"2436_CR77","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1186\/s13019-024-03059-1","volume":"19","author":"R Vonthein","year":"2024","unstructured":"Vonthein R, et al. Taurolidine-containing solution for reducing cardiac implantable electronic device infection-early report from the European TauroPace\u2122 registry. J Cardiothorac Surg. 2024;19(1):592.","journal-title":"J Cardiothorac Surg"},{"issue":"10","key":"2436_CR78","doi-asserted-by":"publisher","first-page":"euad306","DOI":"10.1093\/europace\/euad306","volume":"25","author":"S Borov","year":"2023","unstructured":"Borov S, et al. Use of a taurolidine containing antimicrobial wash to reduce cardiac implantable electronic device infection. EP Europace. 2023;25(10):euad306. https:\/\/doi.org\/10.1093\/europace\/euad306","journal-title":"EP Europace"},{"issue":"6","key":"2436_CR79","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1128\/AAC.44.6.1720-1724.2000","volume":"44","author":"C Torres-Viera","year":"2000","unstructured":"Torres-Viera C, et al. Activities of taurolidine in vitro and in experimental enterococcal endocarditis. Antimicrob Agents Chemother. 2000;44(6):1720\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"2436_CR80","doi-asserted-by":"crossref","unstructured":"Olthof ED et al. Long-term Taurolidine lock therapy is more effective in preventing catheter related bloodstream infections in adult home parenteral nutrition patients than heparin: a follow-up of 212 patients. 2013.","DOI":"10.1016\/S0261-5614(13)60246-0"},{"issue":"12","key":"2436_CR81","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.hrthm.2023.08.015","volume":"20","author":"JC Diaz","year":"2023","unstructured":"Diaz JC, et al. Chlorhexidine gluconate pocket lavage to prevent cardiac implantable electronic device infection in high-risk procedures. Heart Rhythm. 2023;20(12):1674\u201381.","journal-title":"Heart Rhythm"},{"issue":"1","key":"2436_CR82","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12872-017-0689-9","volume":"17","author":"FG Kang","year":"2017","unstructured":"Kang FG, et al. Effect of pocket irrigation with antimicrobial on prevention of pacemaker pocket infection: a meta-analysis. BMC Cardiovasc Disord. 2017;17(1):256.","journal-title":"BMC Cardiovasc Disord"},{"key":"2436_CR83","first-page":"1319","volume-title":"Device Pocket Antibiotic Irrigation Provides No CIED-Pocket Infection Prophylaxis Advantage Compared to Normal Saline","author":"D Rodriguez","year":"2022","unstructured":"Rodriguez D, et al. Device Pocket Antibiotic Irrigation Provides No CIED-Pocket Infection Prophylaxis Advantage Compared to Normal Saline. Volume 8. JACC: Clinical Electrophysiology; 2022. pp. 1319\u201320. 10."},{"issue":"14","key":"2436_CR84","first-page":"5218","volume":"26","author":"C Monaco","year":"2022","unstructured":"Monaco C, et al. Local gentamicin-collagen sponge reduces cardiovascular implantable electronic device infections and pocket hematoma. Eur Rev Med Pharmacol Sci. 2022;26(14):5218\u201324.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"2436_CR85","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.repc.2023.01.023","volume":"42","author":"A Matteucci","year":"2023","unstructured":"Matteucci A, et al. Treatment with gentamicin-impregnated collagen sponges in reducing infection of implantable cardiac devices: 10-year analysis with propensity score matching. Rev Port Cardiol. 2023;42(8):711\u20137.","journal-title":"Rev Port Cardiol"},{"issue":"1","key":"2436_CR86","doi-asserted-by":"crossref","first-page":"9922994","DOI":"10.1155\/joic\/9922994","volume":"2026","author":"O Azizy","year":"2026","unstructured":"Azizy O, et al. Gentamicin\u2013Collagen Sponge Use in the Implant Pocket for the Prevention of Cardiac Implantable Electronic Device Infections. J Interv Cardiol. 2026;2026(1):9922994.","journal-title":"J Interv Cardiol"},{"issue":"1","key":"2436_CR87","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.hrthm.2015.08.039","volume":"13","author":"L Boersma","year":"2016","unstructured":"Boersma L, et al. Infection and mortality after implantation of a subcutaneous ICD after transvenous ICD extraction. Heart Rhythm. 2016;13(1):157\u201364.","journal-title":"Heart Rhythm"},{"issue":"10","key":"2436_CR88","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jamacardio.2024.2050","volume":"9","author":"JP Singh","year":"2024","unstructured":"Singh JP, et al. Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure. JAMA Cardiol. 2024;9(10):871\u20139.","journal-title":"JAMA Cardiol"},{"issue":"Supplement1","key":"2436_CR89","doi-asserted-by":"publisher","first-page":"ehab724","DOI":"10.1093\/eurheartj\/ehab724.0316","volume":"42","author":"A Rosier","year":"2021","unstructured":"Rosier A, et al. A novel machine learning algorithm has the potential to reduce by 1\/3 the quantity of ILR episodes needing review. Eur Heart J. 2021;42(Supplement1):ehab724\u20130316. https:\/\/doi.org\/10.1093\/eurheartj\/ehab724.0316","journal-title":"Eur Heart J"},{"issue":"10","key":"2436_CR90","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.hrthm.2024.11.029","volume":"22","author":"N Varma","year":"2025","unstructured":"Varma N, et al. Impact of a universal monitoring system (third party) on outcomes of ICD patients: A nationwide study. Heart Rhythm. 2025;22(10):2661\u20138.","journal-title":"Heart Rhythm"},{"issue":"11","key":"2436_CR91","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.3390\/ijms24119739","volume":"24","author":"D Moreno","year":"2023","unstructured":"Moreno D, et al. Comparison of the Antibacterial Effect of Silver Nanoparticles and a Multifunctional Antimicrobial Peptide on Titanium Surface. Int J Mol Sci. 2023;24(11):9739. https:\/\/doi.org\/10.3390\/ijms24119739","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2436_CR92","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/europace\/euv139","volume":"18","author":"HC Chen","year":"2016","unstructured":"Chen HC, et al. Bundled preparation of skin antisepsis decreases the risk of cardiac implantable electronic device-related infection. Europace. 2016;18(6):858\u201367.","journal-title":"Europace"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02436-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-026-02436-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02436-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:44:34Z","timestamp":1792086274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-026-02436-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2436"],"URL":"https:\/\/doi.org\/10.1007\/s11886-026-02436-7","relation":{},"ISSN":["1534-3170"],"issn-type":[{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"28 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This review article did not involve human participants or patient data. Ethics committee approval was therefore not required.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Benito Baldauf (BB) currently holds or has held, during the past three years, positions as a medical consultant and\/or advisory board member for Abbott, BiolineSupply, Biotronik, Boston Scientific, CRM Microport, Crosstec GmbH, Drugsales Ltd., DSE Holding T\u00fcrkiye, Implicity, Kappamed, Kimal PLC, M3 Medical\/Ecclipse Medical, Medintek, Medival SRL, Medtronic, Philips\/Spectranetics, Sintec SRL, Tauro-Implant GmbH, Tauropharm GmbH, Transcutan, Transaxis, and 4G. The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Artificial intelligence (AI)-based tools, including software incorporating AI-assisted features, were used for language and grammar editing and to assist with the refinement and finalization of Fig.\u00a01 and the central illustration, which were designed by the authors. AI was not used to generate scientific content, analyze or interpret data, create tables, or formulate scientific conclusions. All AI-assisted outputs were reviewed, edited, and approved by the authors, who take full responsibility for the accuracy, integrity, and final content of the manuscript and its figures.","order":5,"name":"Ethics","label":"Use of Artificial Intelligence","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"111"}}